Association of Care Coordination Experience and Health Services Use with Main Provider Type for Children with

Neal A deJong1, Marie Wofford2, Paula H Song3

  • 1Division of General Pediatrics and Adolescent Medicine, UNC School of Medicine, Chapel Hill, NC.

Insights

Families of children with inflammatory bowel disease (IBD) may face care coordination trade-offs. Identifying a primary care physician (PCP) as the main provider increased use of primary and mental health services but may impact IBD care coordination.

Area of Science:

  • Pediatric gastroenterology
  • Health services research
  • Care coordination

Background:

  • Children with inflammatory bowel disease (IBD) require coordinated care across multiple specialists.
  • The perceived main provider (primary care physician vs. gastroenterologist) may influence care coordination and health service utilization.
  • Understanding these differences is crucial for optimizing care for pediatric IBD patients.

Purpose of the Study:

  • To describe the care coordination experience for families of children with IBD.
  • To compare health service utilization between families who identified a primary care physician (PCP) or a gastroenterologist as the child's main provider.

Main Methods:

  • Cross-sectional survey of 101 children (aged 6-19) with IBD and their parents.
  • Assessed care coordination experiences and past-year health services use.
  • Used bivariate testing and logistic regression to compare outcomes based on main provider identification, adjusting for covariates.

Main Results:

  • 41% of families identified a PCP as the main provider.
  • Gastroenterologist as main provider showed higher performance on some care coordination indicators.
  • PCP as main provider was associated with increased use of primary care and mental health services when needed.
  • No difference in IBD-related hospitalizations or emergency department visits between groups.

Conclusions:

  • Care coordination quality and access to non-disease-specific services may differ based on the perceived main provider for children with IBD.
  • Enhanced coordination between primary care, specialty care, and families is needed to improve overall care quality for pediatric IBD patients.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
560
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
485
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
526
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
278
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
306
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
615